fda stance on compounded semaglutide How Crackdowns Are Affecting GLP-1 Use In 2025 FDA warns about compounded versions

At BetterMe Rx, we believe patients deserve honest, science-based information about emerging trends in healthcare

J Diabetes Investig 12(9):16421650

This on-demand, virtual training runs through the clinical, operational and legal steps to opening a successful and legally compliant medical weight loss program in your practice.

Skin removal surgeries can take weeks to recover from, with results varying depending on the health of the client and how much skin was removed

Regulatory and Ethical Considerations Current Approval Status (2026) As of 2026, neither cagrilintide nor retatrutide has received FDA approval for obesity treatment or metabolic applications